CLX earning looking good with historical value.
Price broken through 2 layers of support and reaching a 3rd.
Long position for earnings and in case of S/L skip, remaining long back into channel.
Long position:
Risk: 1.5-2.5% according to apetite. $115.00 S/L.
Reward: 10% reward potential. $130.00 will take a 50% partial
P had a decent run lately due to good news and favorable earnings.
The move to digital platforms is going well but unsustainable IMO.
Waiting for the confirmation at the long term trend line.
A break - A very good potential LONG with ~20% upside.
A rejection - A very, very good short all the way down to $6.
A small long until trend line is a good swing trade.
MYGN took a beating after it's guidance underwhelm last quarter.
I do believe that the reaction was overdone.
MYGN has healthy revenue streams and growing drug and generics demand.
TA confirms a re-entering into trading range of:
PT 1: $25.00 for a ~20%+ return.
PT 2: $30.00 for a 50% return.
KSS had a great season with good growth.
Improved retail spending is sending revenue streams higher.
First target is anywhere over $50.
Final target if $50 breaks is $60 for 2016.
VRX pushing towards the Avg. Analyst Estimate of 38.10.
News & Analyst driven. Volatile.
$38.00 PT -
Breakout over $38.15 is a clear strong buy signal.
Rejection is a short back into the channel.
With the declining business model and the shift to online "downloads" GME is fairing poorly.
R/R is unfavorable but nimble in comparison to the balance sheet.
Down side potential of ~30%
Upside (S/L) set at midpoint, or 15% retrace.
Relative R/R factors:
Long trend seen to continue with return to growth in 2017.
New India and Middle East markets seen as extreme growth opportunity.
10% loss where S/L is placed.
25% potential profit back to ATH.
